Evidence map›Paper›PMID 20566356›Full record

ReviewMechanisms of ageing and development

Mitochondrial oxidative stress and mammalian healthspan.

Jonathan Wanagat, Dao-Fu Dai, Peter Rabinovitch

Abstract readReview
In one paragraph

Review in Mechanisms of ageing and development. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Mitochondria, Estrogen and Female Brain Aging.Frontiers in aging neuroscience · 2018
    Review
  7. Review
  8. Review
  9. Mitochondrial dysfunction in cardiac aging.Biochimica et biophysica acta · 2015
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Basic biology of skeletal aging: role of stress response pathways.The journals of gerontology. Series A, Biological sciences and medical sciences · 2013
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jonathan WanagatDepartment of Medicine, Division of Geriatrics, UCLA, Los Angeles, CA 90095, USA.
Dao-Fu Dai
Peter Rabinovitch

Funding

SPECIFICITY OF OXYGEN DNA DAMAGE AND MUTAGENESISP01AG001751 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 1985 to 2021
$29.6M
University of Washington Nathan Shock Center of Excellence in the Basic Biology of AgingP30AG013280 · NIA · UNIVERSITY OF WASHINGTON · PI Su-In Lee · 1995 to 2026
$27.1M
Cardiomyocyte mitochondria and mtROS in cardiac aging, hypertrophy and failureR01HL101186 · NHLBI · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 2010 to 2013
$2.5M
Interrogating and manipulating mitochondrial ROS, energetics and proteomicsRC1AG035844 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 2009 to 2010
$505k
Mitochondrial genetics in skeletal muscle agingK08AG032873 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WANAGAT, JONATHAN · 2009 to 2013
$473k
NHLBI NIH HHS R01 HL101186NIA NIH HHS P01 AG001751NIA NIH HHS P30 AG013280NIA NIH HHS RC1 AG035844
6 · The paper itself

Abstract

Aging of the American society is leading to a growing need for disease-modifying interventions to treat age-related diseases and enhance healthspan. Mitochondria and mitochondrially generated reactive oxygen species appear to play a central role in these processes and are a likely target for interventions. Conventional, untargeted antioxidants have not demonstrated a clear benefit in human studies. As a result, approaches have been developed to target antioxidants specifically to mitochondria. Studies have employed a wide array of targeted molecules including antioxidant enzymes such as catalase, peroxiredoxin, superoxide dismutases and small molecular compounds which recapitulate the antioxidant activities of these enzymes. Lifespan and healthspan effects differ between interventions suggesting varied roles for specific mitochondrial reactive oxygen species and their impact on usual aging. Consistent findings in myocardial protection across various interventions support a focus on the impact of cardiac aging on healthspan. The advancement of mitochondrially targeted small-molecule antioxidants suggests the prospect of swift translation to human use.

Indexed as

Age FactorsAgingAnimalsAntioxidantsCellular SenescenceHumansLongevityMitochondriaOxidative StressReactive Oxygen SpeciesAntioxidantsReactive Oxygen Species

Identifiers

PMID20566356
PMCPMC2933331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.